New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

Amgen gains ground during first quarter

Increased demand, higher prices make 2015 outlook positive

It was a good first quarter for Amgen.

Product sales during the first quarter of 2015, were 12% higher, total revenue grew 11% and net income rose 34% when all compared to the same period last year, according to Medical Marketing & Media.

What is driving this? Experts say higher prices and increased demand are part of the reason.

Sales of Enbrel, a drug used to treat rheumatoid arthritis also rose 13%, whiles sales of Xgeva increase by 22%, in the first quarter of this year compared to last year during the same period, according to the article.

This comes as the company introduced its cardiovascular strategy, which includes a sales push of Corlanor, a heart failure medication recently approved by the FDA.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts